H. D. Bakker

781 total citations
28 papers, 556 citations indexed

About

H. D. Bakker is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, H. D. Bakker has authored 28 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Biochemistry, 14 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in H. D. Bakker's work include Metabolism and Genetic Disorders (21 papers), Neonatal Health and Biochemistry (6 papers) and Diet and metabolism studies (6 papers). H. D. Bakker is often cited by papers focused on Metabolism and Genetic Disorders (21 papers), Neonatal Health and Biochemistry (6 papers) and Diet and metabolism studies (6 papers). H. D. Bakker collaborates with scholars based in Netherlands, United States and Italy. H. D. Bakker's co-authors include A. H. van Gennip, N. G. G. M. Abeling, Annet M. Bosch, Albert H. Gennip, Frits A. Wijburg, H. F. M. Busch, R. J. A. Wanders, I. E. M. Luyt‐Houwen, H. R. Scholte and L. P. Kuyt and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Clinica Chimica Acta and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

H. D. Bakker

28 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. D. Bakker Netherlands 14 354 267 175 122 83 28 556
R. Baumgartner Switzerland 17 310 0.9× 293 1.1× 82 0.5× 71 0.6× 168 2.0× 38 646
U. Caruso Italy 12 294 0.8× 240 0.9× 54 0.3× 124 1.0× 92 1.1× 38 504
E. Mönch Germany 13 519 1.5× 347 1.3× 287 1.6× 106 0.9× 84 1.0× 37 686
Alice Mazur United States 11 270 0.8× 164 0.6× 143 0.8× 87 0.7× 66 0.8× 13 570
Maria Luı́s Cardoso Portugal 15 294 0.8× 257 1.0× 91 0.5× 99 0.8× 89 1.1× 29 542
François Eyskens Belgium 17 331 0.9× 462 1.7× 158 0.9× 83 0.7× 80 1.0× 38 779
Stephen Cederbaum United States 17 682 1.9× 508 1.9× 270 1.5× 119 1.0× 158 1.9× 24 919
C. R. Roe United States 9 524 1.5× 409 1.5× 164 0.9× 51 0.4× 72 0.9× 10 691
Kathryn Moseley United States 17 672 1.9× 416 1.6× 410 2.3× 103 0.8× 178 2.1× 26 833
Birthe Roos Netherlands 11 178 0.5× 187 0.7× 99 0.6× 64 0.5× 69 0.8× 15 496

Countries citing papers authored by H. D. Bakker

Since Specialization
Citations

This map shows the geographic impact of H. D. Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. D. Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. D. Bakker more than expected).

Fields of papers citing papers by H. D. Bakker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. D. Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. D. Bakker. The network helps show where H. D. Bakker may publish in the future.

Co-authorship network of co-authors of H. D. Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of H. D. Bakker. A scholar is included among the top collaborators of H. D. Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. D. Bakker. H. D. Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vlaardingerbroek, Hester, Gerard Hornstra, Tom J. de Koning, et al.. (2006). Essential polyunsaturated fatty acids in plasma and erythrocytes of children with inborn errors of amino acid metabolism. Molecular Genetics and Metabolism. 88(2). 159–165. 39 indexed citations
2.
Overweg‐Plandsoen, W. C. G., J.E.M. Groener, W. Onkenhout, et al.. (2003). GLUT‐1 deficiency without epilepsy—an exceptional case. Journal of Inherited Metabolic Disease. 26(6). 559–563. 42 indexed citations
3.
Bosch, Annet M., et al.. (2003). Clinical features of galactokinase deficiency:A review of the literature. Journal of Inherited Metabolic Disease. 25(8). 629–634. 90 indexed citations
4.
Abeling, N. G. G. M., A. H. van Gennip, Henk J. Blom, et al.. (1999). Rapid diagnosis and methionine administration: Basis for a favourable outcome in a patient with methylene tetrahydrofolate reductase deficiency. Journal of Inherited Metabolic Disease. 22(3). 240–242. 16 indexed citations
5.
Haas, Válerie de, et al.. (1998). The success of dietary protein restriction in alkaptonuria patients is age‐dependent. Journal of Inherited Metabolic Disease. 21(8). 791–798. 42 indexed citations
6.
Knaap, Marjo S. van der, H. D. Bakker, & J. Valk. (1998). MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency.. American Journal of Neuroradiology. 19(2). 378–82. 34 indexed citations
7.
Houten, Mark van, et al.. (1997). Does impaired growth of PKU patients correlate with the strictness of dietary treatment?. Acta Paediatrica. 86(8). 816–818. 24 indexed citations
8.
Bosman, D. K., Carla E. M. Hollak, Johannes M. F. G. Aerts, & H. D. Bakker. (1996). The effect of enzyme therapy in a patient with Gaucher disease type III. Journal of Inherited Metabolic Disease. 19(5). 703–704. 1 indexed citations
9.
Scholte, H. R., H. F. M. Busch, H. D. Bakker, et al.. (1995). Riboflavin-responsive complex I deficiency. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1271(1). 75–83. 71 indexed citations
10.
Abeling, N. G. G. M., A. H. van Gennip, H. D. Bakker, et al.. (1995). Diagnosis of a new case of trimethylaminuria using direct proton NMR spectroscopy of urine. Journal of Inherited Metabolic Disease. 18(2). 182–184. 18 indexed citations
11.
Gennip, A. H. van, N. G. G. M. Abeling, A. E. M. Stroomer, Henk Overmars, & H. D. Bakker. (1994). The detection of molybdenum cofactor deficiency: Clinical symptomatology and urinary metabolite profile. Journal of Inherited Metabolic Disease. 17(1). 142–145. 11 indexed citations
12.
Bakker, H. D., et al.. (1994). Dihydropyrimidine dehydrogenase deficiency presenting with psychomotor retardation and ocular abnormalities. Journal of Inherited Metabolic Disease. 17(5). 640–641. 6 indexed citations
13.
Bakker, H. D., et al.. (1993). Molybdenum-Cofactor Deficiency: An Easily Missed Cause of Neonatal Convulsions. Neuropediatrics. 24(3). 139–142. 28 indexed citations
14.
Bakker, H. D., H.R. Scholte, Jeroen A. L. Jeneson, et al.. (1993). Vitamin‐responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis. Journal of Inherited Metabolic Disease. 17(2). 196–204. 18 indexed citations
15.
Pelt, Jos van, Johannis P. Kamerling, H. D. Bakker, & Johannes F.G. Vliegenthart. (1991). A comparative study of sialyloligosaccharides isolated from sialidosis and galactosialidosis urine. Journal of Inherited Metabolic Disease. 14(5). 730–740. 16 indexed citations
16.
Bakker, H. D., et al.. (1991). Hepatic phosphorylase b kinase deficiency with normal enzyme activity in leukocytes and erythrocytes. Journal of Inherited Metabolic Disease. 14(2). 269–270. 8 indexed citations
17.
18.
Staalman, C. R. & H. D. Bakker. (1984). Mucolipidosis I. Skeletal Radiology. 12(3). 153–161. 1 indexed citations
19.
Bakker, H. D., S.K. Wadman, F. J. van Sprang, et al.. (1975). Tyrosinemia and tyrosyluria in healthy prematures: Time courses not vitamin C-dependent. Clinica Chimica Acta. 61(1). 73–90. 7 indexed citations
20.
Bakker, H. D., P.K. De Bree, D. Ketting, F. J. van Sprang, & S.K. Wadman. (1974). Fructose-1,6-diphosphatase deficiency: Another enzyme defect which can present itself with the clinical features of “tyrosinosis”. Clinica Chimica Acta. 55(1). 41–47. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Baumgartner Breakdown of academic impact, for papers by U. Caruso Breakdown of academic impact, for papers by E. Mönch Breakdown of academic impact, for papers by Alice Mazur Breakdown of academic impact, for papers by Maria Luı́s Cardoso Breakdown of academic impact, for papers by François Eyskens Breakdown of academic impact, for papers by Stephen Cederbaum Breakdown of academic impact, for papers by C. R. Roe Breakdown of academic impact, for papers by Kathryn Moseley Breakdown of academic impact, for papers by Birthe Roos
Rankless by CCL
2026